A randomised phase II multicentre study of ipilimumab with temozolomide vs temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: Ipi-Glio

A randomised phase II multicentre study of ipilimumab with temozolomide vs temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: Ipi-Glio

Bibliographic Details
Main Authors:	Mulholland, PJ, Brown, NF, McBain, C, Brazil, L, Peoples, S, Jefferies, S, Harris, F, Plaha, P, Vinayan, A, Brooks, C, Hussain, S, Dutton, SJ, Ng, S, Levy, S, Coutts, T
Format:	Conference item
Language:	English
Published:	American Society of Clinical Oncology 2023

Similar Items

A phase II open label, randomised study of ipilimumab with temozolomide versus temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: the Ipi-Glio trial protocol
by: Brown, NF, et al.
Published: (2020)

A phase II open label, randomised study of ipilimumab with temozolomide versus temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: the Ipi-Glio trial protocol
by: Nicholas F. Brown, et al.
Published: (2020-03-01)

Patterns of relapse in glioblastoma multiforme following concomitant chemoradiotherapy with temozolomide.
by: Sherriff, J, et al.
Published: (2013)

Randomized trial of the combination of lomeguatrib and temozolomide compared with temozolomide alone in chemotherapy naive patients with metastatic cutaneous melanoma.
by: Ranson, M, et al.
Published: (2007)

Association between survival and levetiracetam use in glioblastoma patients treated with temozolomide chemoradiotherapy
by: Tae Hoon Roh, et al.
Published: (2020-07-01)

Quinacrine enhances temozolomide cytotoxicity in temozolomide-sensitive and -resistant glioblastoma cells
by: Pingde Zhang, et al.
Published: (2018-01-01)

Temozolomide-Induced Myelodysplasia
by: Ethan A. Natelson, et al.
Published: (2010-01-01)

Associated adverse outcomes with tumor treating fields when combined to temozolomide versus temozolomide alone for the treatment of glioblastoma: a meta-analysis of randomized trials
by: Yuanyuan Chen, et al.
Published: (2025-02-01)

The Definition and Delineation of the Target Area of Radiotherapy Based on the Recurrence Pattern of Glioblastoma After Temozolomide Chemoradiotherapy
by: Lin Zheng, et al.
Published: (2021-02-01)

Temozolomide – Just a Radiosensitizer?
by: Bernd Kaina, et al.
Published: (2022-06-01)

Temozolomide in treatment resistant prolactinomas
by: V. N. Shree, et al.
Published: (2018-08-01)

Effectiveness of interferon-beta and temozolomide combination therapy against temozolomide-refractory recurrent anaplastic astrocytoma
by: Arai Hajime, et al.
Published: (2007-08-01)

Combining Bevacizumab with Temozolomide Increases the Antitumor Efficacy of Temozolomide in a Human Glioblastoma Orthotopic Xenograft Model
by: Véronique Mathieu, et al.
Published: (2008-12-01)

Combined Delivery of Temozolomide and siPLK1 Using Targeted Nanoparticles to Enhance Temozolomide Sensitivity in Glioma
by: Shi H, et al.
Published: (2020-05-01)

Anlotinib Alone or in Combination With Temozolomide in the Treatment of Recurrent High-Grade Glioma: A Retrospective Analysis
by: Qunying Yang, et al.
Published: (2021-12-01)

Mechanism of acquired temozolomide resistance in glioblastoma
by: McFaline-Figueroa, José L
Published: (2014)

Intracranial metastatic esthesioneuroblastoma responsive to temozolomide.
by: Wick, W, et al.
Published: (2004)

Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma
by: Dipongkor Saha, et al.
Published: (2020-05-01)

Theoretical search of crystal polymorphs of temozolomide
by: David Stephen Arputharaj, et al.
Published: (2022-06-01)

Temozolomide in aggressive pituitary adenomas and carcinomas
by: Leon D. Ortiz, et al.
Published: (2012-01-01)

Complexation and enhancement of temozolomide solubility with cyclodextrins
by: Berna Gürten, et al.
Published: (2018-07-01)

Long-term real-world (RW) outcomes in patients with advanced melanoma (MEL) treated with ipilimumab (IPI) and non-IPI therapies: IMAGE study
by: Dalle, S, et al.
Published: (2019)

A Multicenter Randomized Bioequivalence Study of a Novel Ready-to-Use Temozolomide Oral Suspension vs. Temozolomide Capsules
by: François Ducray, et al.
Published: (2023-11-01)

An overview of glioblastoma multiforme and temozolomide resistance: can LC-MS-based proteomics reveal the fundamental mechanism of temozolomide resistance?
by: Milan Teraiya, et al.
Published: (2023-04-01)

Survival benefits of hypofractionated radiotherapy combined with temozolomide or temozolomide plus bevacizumab in elderly patients with glioblastoma aged ≥ 75 years
by: Makoto Ohno, et al.
Published: (2019-11-01)

Investigating acquired temozolomide resistance in adult glioblastoma
by: Wong, ZY
Published: (2020)

Importance of Autophagy Regulation in Glioblastoma with Temozolomide Resistance
by: Young Keun Hwang, et al.
Published: (2024-08-01)

An Unusual Case of Aplastic Anemia Caused by Temozolomide
by: Gazi Comez, et al.
Published: (2010-01-01)

Temozolomide-associated blepharoconjunctivitis: a case report
by: Tom Kornhauser, et al.
Published: (2024-04-01)

Considering the Experimental Use of Temozolomide in Glioblastoma Research
by: Verena J. Herbener, et al.
Published: (2020-06-01)

Temozolomide Chronotherapy in Glioma: A Systematic Review
by: Jason L. Jia, et al.
Published: (2023-02-01)

Temozolomide and Other Alkylating Agents in Glioblastoma Therapy
by: Hannah Strobel, et al.
Published: (2019-09-01)

Application progress of temozolomide in clinical tumor chemotherapy
by: Cheng ZHONG, et al.
Published: (2013-12-01)

Application and advance of temozolomide in the treatment of pituitary adenomas
by: Yi-guang LIN, et al.
Published: (2015-12-01)

CNTs-COOH Paste Electrode for Detection of Temozolomide
by: Sathish Reddy, et al.
Published: (2020-02-01)

Temozolomide and cisplatin in relapsed/refractory acute leukemia
by: Rasul Muhammad, et al.
Published: (2009-05-01)

A randomized phase III study of short-course radiotherapy combined with Temozolomide in elderly patients with newly diagnosed glioblastoma; Japan clinical oncology group study JCOG1910 (AgedGlio-PIII)
by: Yoshiki Arakawa, et al.
Published: (2021-10-01)

PARADIGM-2: Two parallel phase I studies of olaparib and radiotherapy or olaparib and radiotherapy plus temozolomide in patients with newly diagnosed glioblastoma, with treatment stratified by MGMT status
by: Ben Fulton, et al.
Published: (2018-01-01)

O(6)-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatrib.
by: Watson, A, et al.
Published: (2009)

Brain Radiotherapy plus Concurrent Temozolomide versus Radiotherapy Alone for Patients with Brain Metastases: A Meta-Analysis.
by: Qian Zhao, et al.
Published: (2016-01-01)